Evidence map›Paper›PMID 32351991›Full record

Trial reportBioMed research international2020

Pregnancy and Venous Thromboembolism: Risk Factors, Trends, Management, and Mortality.

Mohammed A Alsheef, Alhanouf M Alabbad, Rowida A Albassam, Rawan M Alarfaj, Abdul Rehman Z Zaidi, Ohoud Al-Arfaj, Amani Abu-Shaheen

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Obesity, pregnancy, and prophylaxis for venous thromboembolism.Journal of family medicine and primary care · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mohammed A AlsheefMedical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-1651-1158
Alhanouf M AlabbadCollege of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Rowida A AlbassamCollege of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Rawan M AlarfajCollege of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Abdul Rehman Z ZaidiMedical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-0137-9633
Ohoud Al-ArfajDepartment of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia.
Amani Abu-ShaheenDepartment of Scientific Writing, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-1019-5548
King Fahd Medical City · SAPrincess Nourah bint Abdulrahman University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPregnancy is one of the major risk factors for the development of venous thromboembolism (VTE).

objectiveTo elucidate the circumstances surrounding pregnancy-induced deep vein thrombosis (DVT) and pulmonary embolism (PE), assess potential factors triggering thrombosis (e.g., thrombophilia, obesity, age, parity, and family history), initial and long-term management, and assess recurrence rate and mortality for VTE in pregnant Saudi women.

methodsA retrospective chart review of 180 patients with objectively confirmed VTE (DVT, PE, or both) that occurred during pregnancy, or the postpartum period was conducted. All patients who experienced episodes of objectively confirmed VTE were included.

resultsOverall, 180 patients were included. Further, 60% (

conclusionPregnancy was the most common provoking factor for VTE in our study. Pregnant women should undergo formal, written assessments of risk factors for VTE at the first visit and delivery. Larger studies with a randomized design, and control groups are required to confirm the current findings.

Indexed as

Pregnancy Complications, CardiovascularVenous ThromboembolismAdultFemaleHumansPregnancyRetrospective StudiesRisk Factors

Identifiers

PMID32351991
PMCPMC7174915
OpenAlexW3016123587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.